|Bid||17.21 x 1000|
|Ask||17.22 x 800|
|Day's Range||17.05 - 17.34|
|52 Week Range||9.80 - 31.56|
|Beta (5Y Monthly)||1.94|
|PE Ratio (TTM)||17.12|
|Earnings Date||Aug. 10, 2016 - Aug. 15, 2016|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar. 12, 2020|
|1y Target Est||19.03|
MONTREAL, Oct. 27, 2020 /CNW Telbec/ - (NYSE: CAE) (TSX: CAE) – CAE will release its fiscal year 2021 second quarter results on Tuesday, November 10, 2020.
Trump's re-election could unlock value in stocks like Enbridge Inc. (TSX:ENB)(NYSE:ENB).The post If Trump Wins, These 3 Canadian Stocks Will Surge appeared first on The Motley Fool Canada.
TALTZ is now approved to treat patients across the axSpA spectrum, including ankylosing spondylitis and non-radiographic axSpA TORONTO, Oct. 19, 2020 /CNW/ - On October 14, 2020, Health Canada approved TALTZ® for the treatment of adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation who have responded inadequately to, or are intolerant to conventional therapy.